Exercise for Patients With HIV Infections
Primary Purpose
HIV Infections, Lipodystrophy, Inflammation
Status
Unknown status
Phase
Phase 2
Locations
Germany
Study Type
Interventional
Intervention
Exercise
Sponsored by
About this trial
This is an interventional supportive care trial for HIV Infections focused on measuring HIV, Exercise, Inflammation, Quality of life, Lipodystrophia
Eligibility Criteria
Inclusion Criteria:
- Age 18 to 65
- HIV infection
- Antiviral therapy
- Understanding of written German
Exclusion Criteria:
- Diabetes mellitus
- All conditions which can be aggravated by exercise
Sites / Locations
- Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30Recruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention
Control
Arm Description
Outcomes
Primary Outcome Measures
Maximal oxygen uptake (VO2max)
Secondary Outcome Measures
Quality of life
Indicators of fat metabolism
Markers of inflammation
Full Information
NCT ID
NCT00910936
First Posted
May 29, 2009
Last Updated
December 18, 2009
Sponsor
Charite University, Berlin, Germany
1. Study Identification
Unique Protocol Identification Number
NCT00910936
Brief Title
Exercise for Patients With HIV Infections
Official Title
Effects of an Exercise Program on Metabolic Parameters of Patients With a HIV Infection.
Study Type
Interventional
2. Study Status
Record Verification Date
December 2009
Overall Recruitment Status
Unknown status
Study Start Date
May 2009 (undefined)
Primary Completion Date
January 2010 (Anticipated)
Study Completion Date
February 2010 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Charite University, Berlin, Germany
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators will evaluate the effects of an endurance exercise program on the physical performance, the well being, and indicators of metabolic function in patients with an HIV infection.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections, Lipodystrophy, Inflammation
Keywords
HIV, Exercise, Inflammation, Quality of life, Lipodystrophia
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Title
Control
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
12 weeks endurance training, 3 times weekly for 35 minutes
Primary Outcome Measure Information:
Title
Maximal oxygen uptake (VO2max)
Time Frame
At recruitment and after 12 weeks
Secondary Outcome Measure Information:
Title
Quality of life
Time Frame
At recruitment and after 12 weeks
Title
Indicators of fat metabolism
Time Frame
At recruitment and after 12 weeks
Title
Markers of inflammation
Time Frame
At recruitment and after 12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18 to 65
HIV infection
Antiviral therapy
Understanding of written German
Exclusion Criteria:
Diabetes mellitus
All conditions which can be aggravated by exercise
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Fernando Dimeo, MD
Phone
+493084452098
Email
fernando.dimeo@charite.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fernando Dimeo, MD
Organizational Affiliation
Charite University, Berlin, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30
City
Berlin
ZIP/Postal Code
12200
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fernando Dimeo, MD
Phone
+493084452098
Email
fernando.dimeo@charite.de
12. IPD Sharing Statement
Learn more about this trial
Exercise for Patients With HIV Infections
We'll reach out to this number within 24 hrs